Financials Huaxia Eye Hospital Group Co.,Ltd.

Equities

301267

CNE100005WL5

Healthcare Facilities & Services

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-20 pm EDT			5-day change	1st Jan Change
25.3 ^CNY	-1.71%		-0.39%	-21.16%

Apr. 30	Huaxia Eye Hospital Group Co.,Ltd. agreed to acquire Xiamen Huaxia Juxin No. 1 Investment Consulting Co., Ltd. from Xiamen Huaxia Juxin No. 1 Investment Partnership Enterprise (Limited Partnership) and Nanjing Xinke Dongzheng 01 Venture Capital Partnership Enterprise (Limited Partnership) for approximately CNY 500 million.	CI
Apr. 26	Huaxia Eye Hospital Group Co.,Ltd. Proposes Final Cash Dividend for 2023	CI

Valuation

Fiscal Period: December	2022	2023	2024	2025	2026
Capitalization ¹	40,942	26,956	21,120	-	-
Enterprise Value (EV) ¹	40,942	26,956	21,120	21,120	21,120
P/E ratio	73.1 x	40.6 x	25.6 x	20.3 x	18.1 x
Yield	0.38%	0.34%	0.43%	-	-
Capitalization / Revenue	12.7 x	6.72 x	4.4 x	3.52 x	3.21 x
EV / Revenue	12.7 x	6.72 x	4.4 x	3.52 x	3.21 x
EV / EBITDA	44 x	22.8 x	15.5 x	12.5 x	11.1 x
EV / FCF	76.1 x	52.4 x	28 x	25.2 x	14 x
FCF Yield	1.31%	1.91%	3.57%	3.98%	7.12%
Price to Book	8.01 x	4.77 x	3.39 x	2.89 x	2.6 x
Nbr of stocks (in thousands)	840,000	840,000	834,775	-	-
Reference price ²	48.74	32.09	25.30	25.30	25.30
Announcement Date	4/23/23	4/25/24	-	-	-

¹CNY in Million²CNY

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December	2021	2022	2023	2024	2025	2026
Net sales ¹	-	3,233	4,013	4,800	5,993	6,571
EBITDA ¹	-	931.1	1,181	1,363	1,695	1,902
EBIT ¹	-	727.4	973.4	1,166	1,469	1,657
Operating Margin	-	22.5%	24.26%	24.28%	24.51%	25.22%
Earnings before Tax (EBT) ¹	-	653.6	854.3	1,048	1,347	1,506
Net income ¹	454.9	511.8	665.9	818.5	1,045	1,173
Net margin	-	15.83%	16.59%	17.05%	17.43%	17.85%
EPS ²	0.6067	0.6667	0.7900	0.9875	1.244	1.397
Free Cash Flow ¹	-	538.2	514.5	754.2	839.6	1,504
FCF margin	-	16.65%	12.82%	15.71%	14.01%	22.89%
FCF Conversion (EBITDA)	-	57.81%	43.58%	55.32%	49.54%	79.09%
FCF Conversion (Net income)	-	105.17%	77.27%	92.15%	80.38%	128.24%
Dividend per Share ²	-	0.1867	0.1100	0.1100	-	-
Announcement Date	10/13/22	4/23/23	4/25/24	-	-	-

¹CNY in Million²CNY

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December	2023 Q1
Net sales	-
EBITDA	-
EBIT	-
Operating Margin	-
Earnings before Tax (EBT)	-
Net income	-
Net margin	-
EPS ¹	0.1800
Dividend per Share	-
Announcement Date	4/23/23

¹CNY

Estimates

Balance Sheet Analysis

Fiscal Period: December	2021	2022	2023	2024	2025	2026
Net Debt	-	-	-	-	-	-
Net Cash position	-	-	-	-	-	-
Leverage (Debt/EBITDA)	-	-	-	-	-	-
Free Cash Flow ¹	-	538	515	754	840	1,504
ROE (net income / shareholders' equity)	-	20.1%	12.4%	13.4%	14.4%	14.6%
ROA (Net income/ Total Assets)	-	-	9.44%	10.8%	11.4%	12.3%
Assets ¹	-	-	7,057	7,596	9,137	9,537
Book Value Per Share ²	-	6.090	6.730	7.460	8.750	9.740
Cash Flow per Share ²	-	0.9200	1.140	1.170	1.710	1.590
Capex ¹	-	232	447	240	336	244
Capex / Sales	-	7.17%	11.13%	4.99%	5.6%	3.72%
Announcement Date	10/13/22	4/23/23	4/25/24	-	-	-

¹CNY in Million²CNY

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Huaxia Eye Hospital Group Co.,Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

25.3 CNY

Average target price

44.27 CNY

Spread / Average Target

+74.98%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Doctor's Office

	1st Jan change	Capi.
HUAXIA EYE HOSPITAL GROUP CO.,LTD.	-21.16%	2.92B
TOPCHOICE MEDICAL CO., INC.	-12.75%	2.95B
AIRSCULPT TECHNOLOGIES, INC.	-48.06%	224M
EUROEYES INTERNATIONAL EYE CLINIC LIMITED	0.00%	226M
MEDSCI HEALTHCARE HOLDINGS LIMITED	-40.88%	191M
AESTHETIC CONNECT	-40.22%	103M

Doctor's Office